Skip to content
Home » PR Newswire » WIRobotics and Ottobock Join Forces to Expand Access to Wearable Robots Across North America

WIRobotics and Ottobock Join Forces to Expand Access to Wearable Robots Across North America

  • The Distribution agreement covers the United States and Canada, with sales through the partnership to begin in the U.S.
  • WIM S is available to U.S. consumers online through Ottobock’s direct-to-consumer platform and WIRobotics USA’s online store.
  • U.S. consumers will be able to try WIM S at select orthotic and prosthetic clinics.

SEOUL, South Korea, Nov. 17, 2026 /PRNewswire/ — WIRobotics, a global robotics company led by Co-CEOs Younbaek Lee and Yongjae Kim, announced that its U.S. subsidiary, WIRobotics USA Inc., signed a distribution and sales agreement with Otto Bock HealthCare LP on October 15. Under the agreement, WIRobotics USA will supply WIM S, the company’s wearable mobility robot, and Ottobock will serve as a distribution partner in the United States and Canada.

Photo credit: WIRobotics
Photo credit: WIRobotics

The partnership will begin in the United States, where consumers will be able to purchase WIM S online through Ottobock’s dedicated direct-to-consumer online platform and WIRobotics USA’s online store, and try the robot initially at select orthotic and prosthetic (O&P) clinics. Based on customer feedback, the companies will consider offering hands-on experiences at more U.S. locations and extending sales through the partnership to Canada. 

The partnership brings together WIRobotics’ wearable robotics technology and Ottobock’s more than 100 years of experience in human mobility. Founded in Germany in 1919, Ottobock has established distribution, clinical care and service networks in the United States and Canada. The companies plan to collaborate on market development, brand building, product training and after-sales service, with WIRobotics USA supporting training and service operations locally.

The agreement marks a major step in WIRobotics’ global expansion. Now in its third year of commercialization, WIM has surpassed 4,000 units in cumulative sales, and the company has expanded sales beyond South Korea to markets including Europe, China and Japan. WIRobotics has been accelerating its international business, with the United States and Canada as key strategic markets. To support this growth, the company established WIRobotics USA Inc. under General Manager Jacob Kim to build local operations in North America.

The companies also see significant opportunities to extend their collaboration to WIM Medi, which WIRobotics is developing for medical use. They view WIM Medi as a natural next step for the partnership, with entry into U.S. and Canadian medical and rehabilitation channels to follow applicable regulatory authorization and a separate agreement.

“Our goal is to make wearable mobility technology easier for people to experience and integrate into everyday life,” said Younbaek Lee, co-CEO of WIRobotics. “Working with Ottobock gives us an opportunity to introduce WIM S to more people across North America. We will expand our engagement with customers in the region and strengthen WIM’s global business foundation.”

“At Ottobock, we are committed to helping people maintain mobility and independence through innovative solutions that support an active lifestyle,” said Scott Schneider, Head of Government/Medical Affairs & Future Development at Ottobock. “WIRobotics is an exceptional company whose technology closely aligns with that vision. Through this partnership, we look forward to introducing WIM S to consumers across North America, beginning with a focused U.S. launch, while exploring new ways for people to experience wearable mobility technology firsthand.“

About WIRobotics
WIRobotics is a global robotics company that develops wearable mobility robots designed to help people move more freely in everyday life. Its WIM series is sold in South Korea and international markets.  Through the development of its ALLEX humanoid robot, the company is also expanding into humanoid robotics and Physical AI. In May 2026, the company raised KRW 95 billion (approximately USD 68 million) in Series B funding to accelerate its global expansion and the commercialization of its robotics technologies. Headquartered in South Korea, the company operates in North America through WIRobotics USA Inc. For more information, visit https://usa.wirobotics.com

About Ottobock
Ottobock, a listed global MedTech champion, combines over 100 years of tradition with outstanding innovative strength in the fields of prosthetics, neuro-orthotics and exoskeletons. Ottobock develops innovative fitting solutions for people with limited mobility and is driving the digitalization of the industry. Founded in Berlin in 1919, the company has business activities in 45 countries with nearly 9,300 employees (FTEs) worldwide and operates the largest international patient care network with more than 430 patient care clinics. Ottobock is shaping the future of human bionics with a strong R&D ratio in the products and components business and over 2,600 patents and patent applications. Ottobock’s mission of improving freedom of movement, quality of life and independence is deeply rooted in the company’s DNA, as is its social commitment: Ottobock has been a partner and supporter of the Paralympics since 1988.

 

ข่าวที่เกี่ยวข้อง

BangkokStyle

ผู้หลงใหลในจังหวะชีวิตของชาวกรุงเทพฯ ปัณณพัทธ์ โกษาแสง (@krapalm) บล็อกเกอร์ที่นำเสนอเรื่องราวการผสมผสานระหว่างเทคโนโลยีล้ำสมัย แฟชั่น ความงาม และไลฟ์สไตล์คนเมืองเข้าไว้ด้วยกันอย่างลงตัว นอกเหนือจากการคอยอัปเดตเทรนด์ไอทีที่ digitalmore.co แล้ว ผมตั้งใจใช้พื้นที่แห่งนี้เพื่อสะท้อนมุมมองและอัปเดตไอเทมใหม่ๆ ที่ตอบโจทย์การใช้ชีวิตยุคใหม่ของคุณ ติดตามไลฟ์สไตล์ในแบบฉบับคนเมืองกับผมได้ที่ช่องทางโซเชียลมีเดียครับ

ดูบทความทั้งหมด →